Overstimulation of nerve growth factors in postinfectious and autoimmune diseases

Pediatric Neurology

Volumn 18, Issue 3, 1998, Pages 231-235

  Riikonen, Raili S ^a   Söderström, Stine ^b   Korhonen, Laura T ^b   Lindholm, Dan B ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR;

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; INFLAMMATION; MALE; PRIORITY JOURNAL; RASMUSSEN SYNDROME;

ADOLESCENT; AUTOIMMUNE DISEASES; BORRELIA INFECTIONS; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; HUMANS; NERVE GROWTH FACTORS; VIRUS DISEASES;

EID: 0345726089     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(97)00204-X     Document Type: Article

References (24)

1. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 237:1987;1154-1162.
2. Thompson C. Apoptosis in the pathogeneis and treatment of disease. Science. 267:1995;1456-1462.
3. Näher-Noe M, Gnahn H, Grundler A, Klingelhöfer J, Weindl A, Conrad B. Determination of nerve growth factor concentrations in human samples by two-site immunoenzymometric assay and bioassay. Eur J Clin Chem Clin Biochem. 31:1993;375-380.
4. Massaro A, Bigon E, Battiston S, Morandi A, Carnevale A, Callegaro L. Nerve growth factor (NGF) in cerebrospinal fluid (CSF) from patients with various neurological disorders. Ital J Neurol Sci. 15:1994;105-108.
5. Longo F, Selak I, Zovickian J, Manthorpe M, Varon S, Hoi Sang U. Neurotrophic activities in cerebrospinal fluid of head trauma patients. Exp Neurol. 84:1984;207-218.
6. Patterson S, Grady M, Botwell M. Nerve growth factor and fibroblast growth factor-like neurotrophic activity in cerebrospinal fluid of brain injured patients. Brain Res. 605:1993;43-49.
7. Laudiero L, Aloe L, Levi-Montalcini R, Schilter D, Gielessen S, Otten U. Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid. Neurosci Lett. 147:1992;91-92.
8. Lappalainen R, Lindholm D, Riikonen R. Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome. J Child Neurol. 11:1996;296-300.
9. Riikonen R, Söderström S, Vanhala R, Lindholm D. Low amount of nerve growth factors in the CSF in intractable infantile spasms (abstract). Int J Dev Neurosci. 14:(suppl 1):1996;46.
10. Lorigados L, Söderström S, Ebendal T. Two-site enzyme immunoassay for beta NGF applied to human patient sera. J Neurosci Res. 32:1992;329-339.
11. Otten U. Nerve growth factor A signaling protein between the nervous and immune systems . Basbaum AI, Besson J-M. Towards the pharmacotherapy of pain. 1991;353-363 Wiley, Philadelphia.
12. Thorpe L, Stach R, Hashim G, Marchetti D, Perez-Polo J. Receptors for nerve growth factor on rat spleen mononuclear cells. J Neurosci Res. 17:1987;128-134.
13. Barret G, Barlet P. The p75 nerve growth factor receptor mediates survival of death depending on the stage of sensory neuron development. Proc Natl Acad Sci USA. 91:1994;6501-6505.
14. Drago J, Kilpatrick T, Koblar S, Talman P. Growth factors Potential therapeutic applications in neurology . J Neurol Neurosurg Psychiatr. 57:1994;445-448.
15. Aebischer P, Scluep M, Deglon N, et al. Intrathecal delivery of CNTF using genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat Med. 2:1994;696-698.
16. Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut R, Sinicropi D. The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med. 2:1996;703-707.
17. Levitzki A, Gazit A. Tyrosinase kinase inhibition An approach to drug development . Science. 267:1995;1782-1788.
18. Pearce B, Steffensen S, Paoletti A, Henriksen S, Buchmeier M. Persistent dentate cell hyperexcitability after neonatal infection with lymphocytic chorionmeningitis virus. J Neurosci. 16:1996;220-228.
19. Bredsen D. Neural apoptosis. Ann Neurol. 38:1995;839-851.
20. Marchini A, Tomkinson B, Cohen J, Kieff E. BHRF1, the Epstein-Barr virus gene with homology to BcL 2, is dispensable for B lymphocyte transformation and virus replication. J Virol. 65:1991;5991-6000.
21. Riikonen R. Infantile spasms Infectious disorders . Neuropediatrics. 24:1993;274-280.
22. Andrews P, Dichter M, Berkovic S, Newton M, McNamara J. Plasmapheresis in Rasmussen's encephalitis. Neurology. 46:1996;242-246.
23. Antel J, Rasmussen T. Rasmussen's encephalitis and the new hat. Neurology. 46:1996;9-11.
24. Riikonen R. Retinal vasculitis caused by rubella. Neuropediatrics. 26:1995;174-176.